Corin TaperFit Stem Orthopedic Hip Implant Recall: Fatigue Testing Failure
Corin recalls orthopedic hip implant component TaperFit Stem (REF 588.3800) due to failure in fatigue testing. Affected units may not withstand repeated use without failure.
Lower-risk recall
Some of the devices did not pass fatigue testing.
Contact the company
What happened, in plain English
Corin is recalling a specific orthopedic hip implant component called the TaperFit Stem. The recall is because some units did not pass fatigue testing, meaning they might fail under repeated use. Read more at govinfonow.com/recall/60378-corin-taperfit-stem-orthopedic-hip-implant-recall-fatigue-testing-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/60378-corin-taperfit-stem-orthopedic-hip-implant-recall-fatigue-testing-failure · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1667-2022
Cite this page
“Corin TaperFit Stem Orthopedic Hip Implant Recall: Fatigue Testing Failure.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60378-corin-taperfit-stem-orthopedic-hip-implant-recall-fatigue-testing-failure. Based on FDA recall #Z-1667-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1667-2022%22&limit=1).
Why it’s dangerous
The implant component failed fatigue testing, which means it may not withstand repeated stress over time. This could lead to failure during normal use, but the risk is not immediate or severe in typical conditions.
Who’s affected
Orthopedic hip surgery patients who received the TaperFit Stem (REF 588.3800) with model number 588.3800 and lot number 494754. Patients who have this implant are most at risk.
How to tell if you have this one
Check for the model number 588.3800 and lot number 494754 on the implant. The product is used in orthopedic hip surgeries and has a unique identifier (UDI) 05055343871065.
- Brand
Corin- Category
Medical device
What to do — step by step
Check Implant Details
Look for model number 588.3800 and lot number 494754 on the implant component.
Where it went and when
Where it was distributed
Distributed in New Jersey.
FDA distribution: “Distribution was made to NJ. There was no military/government distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: New Jersey.
Recall timeline
FDA terminated this recall 3.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1667-2022 (July 12, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1667-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.